Real-time internet of medical things framework for early detection of Covid-19

por Yildirim, Emre, Cicioğlu, Murtaza, Çalhan, Ali
Publicado 2022

Fog-cloud architecture-driven Internet of Medical Things framework for healthcare monitoring

por Yıldırım, Emre, Cicioğlu, Murtaza, Çalhan, Ali
Publicado 2023

Terlipressin and albumin for type 1 hepatorenal syndrome: does bacterial infection affect the response?

por Altun, Reskan, Korkmaz, Murat, Yıldırım, Emre, Öcal, Serkan, Akbaş, Enver, Selçuk, Haldun
Publicado 2015

Glucagon‐like peptide‐1 receptor expression in the human eye

por Hebsgaard, Josephine B., Pyke, Charles, Yildirim, Emre, Knudsen, Lotte B., Heegaard, Steffen, Kvist, Peter H.
Publicado 2018

Impact of patient characteristics on efficacy and safety of once-weekly semaglutide versus dulaglutide: SUSTAIN 7 post hoc analyses

por Pratley, Richard E, Aroda, Vanita R, Catarig, Andrei-Mircea, Lingvay, Ildiko, Lüdemann, Jörg, Yildirim, Emre, Viljoen, Adie
Publicado 2020

Superior weight loss with once-weekly semaglutide versus other glucagon-like peptide-1 receptor agonists is independent of gastrointestinal adverse events

por Lingvay, Ildiko, Hansen, Thomas, Macura, Stanislava, Marre, Michel, Nauck, Michael A, de la Rosa, Raymond, Woo, Vincent, Yildirim, Emre, Wilding, John
Publicado 2020